View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Excellence Awards 2022

Rankings: Business Expansion

By Mihail Gyurev

The 2022 Excellence Rankings for Business Expansion

The Excellence Rankings celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognise the people and companies that are driving change.

Our programme is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community.

Is your company ranked?

If you want to learn more about the Rankings and the range of marketing materials and options available to promote your achievement then please get in touch with us or download the Media Pack:

Contact: Sundeep Makkar – Sundeep.Makkar@Verdict.co.uk

Free White Paper

Clinical Trials Arena Excellence Awards & Rankings 2022 – Media Pack

By Excellence Awards
Enter your details to receive the free paper:

What is Business Expansion?

Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector.

This consists of any projects that have expanded the company’s footprint in the sector, including: contract wins; launching in new territories; launching new product lines; the acquisition and expansion of facilities and real estate; acquisition of new machinery or other assets; improved logistics; partnerships; and significant staff increases.

Themes

During the research period the most common theme – unsurprisingly – within Business Expansion has been continued investment into Covid vaccine and drug development. The Messenger RNA technology is a source of hope to clinical research and trial organisations as well as the general public, as technology that might be applied to produce vaccines for other diseases as it has greatly shortened the time a vaccine needs to be developed and produced.

Significant investment also remains in the fields of cancer and Alzheimer’s drug development. This is unsurprising given the fact that cancer remains one of the leading causes of death in the world, coming in second only after heart desease, while Alzheimer’s disease is the most common cause of dementia.

Elsewhere a significant problem that still plagues the clinical trials field is inefficient trial and patient matching. Within Business Expansion we’ve seen companies trying to solve this problem by harnessing the power of AI and cloud technologies.

Digital solutions are also making a difference in trial management where companies have seen the advantages of such systems in improving the overall efficiency of research and trial organisations by preventing bottlenecks through automation.

Another key trend is the increased prevalence of pharmaceutical companies partnering with CRO organisations to outsource various stages of drug development in order to reduce costs.

Ranking Categories

Partnership Expansion

COMMENDED
Deep LensMedgateScience 37
GileadMedidataSomru BioScience
HALIXNovalGenSouthern Oncology
Hematology-Oncology Associates of Central New YorkNovo NordiskVeeda Clinical Research
Horizon Therapeutics

The Partnership Expansion category consists of companies that have been cooperating with other organisations in carrying out research and development and other initiatives.


Portfolio Expansion

COMMENDED
BioDelivery SciencesInnoCare PharmaPharmaSGP
BiogenMenariniWoodward Pharma

Portfolio Expansion highlights companies that have expanded their product or business portfolios through acquisitions.


Trial Support: Clinical Research Services

COMMENDED
AdvarraInnovadermTransPerfect Life Sciences
Agilex BiolabsJavaraTrialStat
Avance ClinicalProTrialsTriNetX
CalyxPure StorageWake Forest Baptist
CMAXSuperTrans Medical

This category highlights the successful outsourcing of research to CRO organisations. Additionally this category includes companies that have enlarged their CRO service portfolio or the services offered by their dedicated clinical trial platform.


Trial Support: COVID

COMMENDED
Badische Anilin und Soda FabrikCambridge Antibody TechnologyPharm-Olam

This category includes companies that have been recognised for their efforts in supporting Covid related research and development projects.


Trial Support: DCT Support

COMMENDED
LabcorpSignant
LokavantTHREAD
Medidata

This category includes companies that have provided various services to DTC trial organisations. Trial decentralisation is a way for companies to reduce expenditure.


Trial Support: Management

COMMENDED
Deep LensPathAISummit Clinical
LSK Global PharmaReifyVeeva

This category highlights companies that have supplied digital management solutions to clinical trial companies, and clinical trial companies that have invested in such solutions. A holistic management solution is a big step for clinical research companies and deals in this sector can really shape the industry for years to come.


Trial Support: Oncology

COMMENDED
Catalyst Clinical ResearchMoleculinUniversity Hospitals
GenomOncologyPhysiomicsValiRx

This category highlights companies that have supplied digital management solutions to clinical trial companies, and clinical trial companies that have invested in such solutions. A holistic management solution is a big step for clinical research companies and deals in this sector can really shape the industry for years to come.


Trial Support: Recruitment

COMMENDED
Deep LensSolano HematologyTrialbee

This category recognises IT companies supplying clinical trial organisations with digital patient recruitment platforms. The competitive nature of this area makes the successful marketing of such platforms a noteworthy achievement.


Trial Support: Research Facilities

COMMENDED
ARNGeorge ClinicalMedical Research Network
BeaconcureGlaxoSmithKlinePRA Health
CVS HealthLink HealthVeradigm

This category highlights those companies that have expanded their geographical presence by expanding and investing in their network and facilities.


Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena